New Antibacterial Agents & Stewardship
Antimicrobial resistance refers to microbe’s ability to change and become less susceptible to drugs. The development of antimicrobial drugs (antibiotics, antivirals, antifungals and antiparasitics) to treat otherwise life-threatening infections has been one of the most notable medical achievements in human history. Antimicrobial stewardship refers to coordinated interventions designed to improve and measure the appropriate use of antimicrobials by promoting the selection of the optimal antimicrobial drug regimen, dose, duration of therapy, and route of administration.
- Track 1-1 Mechanisms of action, preclinical data & pharmacology of antibacterial agents
- Track 2-2 Pharmacokinetics/pharmacodynamics of antibacterial drugs & therapeutic drug monitoring
- Track 3-3 Pharmacokinetics/pharmacodynamics of antibacterial drugs & therapeutic drug monitoring
- Track 4-4 New antibacterial agents: clinical trials
- Track 5-5 Pharmacoepidemiology, improved prescribing and antibiotic stewardship